![](https://www.diabetesnews.com/wp-content/uploads/2013/06/20100824_-medtronic-headquarters_33-150x150.jpg)
No sooner did news break that the FDA had approved the Medtronic 670G did debate start over whether it deserved to be labeled an artificial pancreas. I wanted to provide my thoughts on why as the editorial director of a diabetes news publication, I felt comfortable using the term for this hybrid automated pump-and-CGM system.